Office of the Attorney General Paul G. Summers NEWS RELEASE Office of the Attorney General at

First Page		Document Content
Date: 2011-07-20 17:25:23 Ketones Benzamides Benzoates Paclitaxel Propionates Competition law Paclitaxel total synthesis Chemistry Bristol-Myers Squibb Organic chemistry		Office of the Attorney General Paul G. Summers NEWS RELEASE Office of the Attorney General at Add to Reading List Source URL: www.tn.gov Download Document from Source Website File Size: 12,26 KB Share Document on Facebook

	Annals of Oncology Advance Access published August 8, 2012 review Annals of Oncology 00: 1–8, 2012 doi:annonc/mds170 DocID: 1prgZ - View Document
	Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona DocID: 1pnOU - View Document
	PDF Document DocID: 1gn3K - View Document
	administration of cytoxan cytoxan dose for breast cancer, fludarabine and cytoxan and follicular lymphoma busulfan cytoxan vp16. cytoxan teatment for dry eyes uric counts cytoxan, infusion rate for cytoxan. cytoxan predn DocID: 1fKBX - View Document
	Drug Topics® Archive February 03, 1997 NEW DRUG APPROVALS OF 1996-Part 1 DocID: 1b0rJ - View Document